KRTL BioTech

As steep patent cliff looms, Shionogi moves to develop its own U.S. sales staff

As steep patent cliff looms, Shionogi moves to develop its own U.S. sales staff

For much of its 141-year history, Japan's Shionogi & Co Ltd has played safe when selling its drugs in the United States and other overseas markets - relying on bigger partners to promote its products and avoiding the cost of maintaining a large sales force.